MARKET

CFMS

CFMS

ConforMIS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7044
-0.0266
-3.64%
After Hours: 0.7099 +0.0055 +0.78% 17:52 08/14 EDT
OPEN
0.7330
PREV CLOSE
0.7310
HIGH
0.7330
LOW
0.7000
VOLUME
237.82K
TURNOVER
--
52 WEEK HIGH
2.680
52 WEEK LOW
0.5003
MARKET CAP
54.63M
P/E (TTM)
-1.8173
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CFMS stock price target is 2.333 with a high estimate of 3.000 and a low estimate of 2.000.

EPS

CFMS News

More
Conformis (CFMS) Investor Presentation - Slideshow
The following slide deck was published by Conformis, Inc. in conjunction with this event.
Seekingalpha · 16h ago
90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements
Clinical research published online in July 2020 in The Journal of Bone and Joint Surgery Reviews found that the patients studied, who all received Conformis patient-specific iTotal PS (posterior-stabilized) knee replacement implants, were 90% satisfied, or ver
GlobeNewswire · 4d ago
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of 76.92% and 32.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/06 00:45
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers
BILLERICA, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Summary * Total revenue of $19.5 million, a decrease of 1% year-over-year on a
GlobeNewswire · 08/05 20:10
Flexion Therapeutics: An Orthopedic Surgeon And Zilretta User Says Short The Stock
Seeking Alpha · 07/30 04:00
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
BILLERICA, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 1
GlobeNewswire · 07/23 21:00
ConforMIS (CFMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
ConforMIS (CFMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/22 16:32
Bullish: Analysts Just Made A Substantial Upgrade To Their Conformis, Inc. (NASDAQ:CFMS) Forecasts
Simply Wall St. · 07/08 12:00

Industry

Medical Equipment, Supplies & Distribution
-1.04%
Healthcare Equipment & Supplies
-1.20%

Hot Stocks

Symbol
Price
%Change

About CFMS

ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.
More

Webull offers kinds of ConforMIS Inc stock information, including NASDAQ:CFMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CFMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CFMS stock methods without spending real money on the virtual paper trading platform.